Patience David, CFO, made one open market purchase of TriSalus Life Sciences ($TLSI) shares in the last year, totaling $15,000, with the most recent on February 23, 2026. This ranks 4,045th among 4,983 insiders averaging $1.5 million across 3.3 buys. She also sold Accelerate Diagnostics ($AXDXQ) shares once for $4,839 on April 1, 2025, ranking 11,406th out of 11,678 insiders averaging $8.6 million across 6.4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Patience David | Chief Financial Officer | P | Common Stock | 3657 | $4.10 | 268,657.0000 | 49,964,311 | 1.38% | 0.01% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Patience David | Chief Financial Officer | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 668,899.0000 | 49,964,311 | 24.12% | 0.26% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Patience David | Chief Financial Officer | A | Common Stock | 65000 | $0.00 | 265,000.0000 | 49,964,311 | 32.50% | 0.13% |
| Aug. 28, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Patience David | Chief Financial Officer | A | Employee Stock Option (right to buy) | 248899 | $0.00 | 538,899.0000 | 32,272,462 | 85.83% | 0.77% |
| Aug. 14, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Patience David | Chief Financial Officer | A | Employee Stock Option (right to buy) | 290000 | $0.00 | 290,000.0000 | 32,272,462 | 9999.99% | 0.90% |
| Aug. 14, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Patience David | Chief Financial Officer | A | Common Stock | 200000 | $0.00 | 200,000.0000 | 32,272,462 | 9999.99% | 0.62% |
| April 1, 2025 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | M | Common Stock | 20000 | $0.00 | 72,144.0000 | 25,210,392 | 38.36% | 0.08% |
| April 1, 2025 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | S | Common Stock | 6816 | $0.71 | 65,328.0000 | 25,210,392 | 9.45% | 0.03% |
| April 1, 2025 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | M | Employee Restricted Stock Units | 20000 | $0.00 | 30,000.0000 | 25,210,392 | 40.00% | 0.08% |
| Feb. 26, 2025 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | M | Common Stock | 1500 | $0.00 | 52,679.0000 | 25,043,822 | 2.93% | 0.01% |
| Feb. 26, 2025 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | S | Common Stock | 535 | $1.09 | 52,144.0000 | 25,043,822 | 1.02% | 0.00% |
| Feb. 26, 2025 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | M | Employee Restricted Stock Units | 1500 | $0.00 | 0.0000 | 25,043,822 | 100.00% | 0.01% |
| May 29, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | A | Employee Restricted Stock Units | 120000 | $0.00 | 120,000.0000 | 0 | 9999.99% | 0.00% |
| April 9, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | M | Employee Restricted Stock Units | 37468 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 9, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | S | Common Stock | 13296 | $0.87 | 51,179.0000 | 0 | 20.62% | 0.00% |
| April 9, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | M | Common Stock | 37468 | $0.00 | 64,475.0000 | 0 | 138.73% | 0.00% |
| March 5, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | A | Employee Restricted Stock Units | 37468 | $0.00 | 37,468.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | M | Common Stock | 1000 | $0.00 | 27,357.0000 | 0 | 3.79% | 0.00% |
| Feb. 26, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | M | Employee Restricted Stock Units | 1000 | $0.00 | 1,500.0000 | 0 | 40.00% | 0.00% |
| Feb. 26, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | S | Common Stock | 350 | $0.96 | 27,007.0000 | 0 | 1.28% | 0.00% |
| Jan. 23, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | A | Common Stock | 16666 | $0.00 | 26,357.0000 | 0 | 171.97% | 0.00% |
| Jan. 23, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Patience David | Chief Financial Officer | A | Common Stock Warrants (right to buy) | 16666 | $0.00 | 16,666.0000 | 0 | 9999.99% | 0.00% |